← Back
Data updated: Mar 10, 2026
XCOVERY
Oncology
XCOVERY is a pharmaceutical company focused on Oncology. Key products include ENSACOVE.
2024
Since
1
Drugs
-
Trials
2
Approved (2yr)
Recent Activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs Phase 3: 1 Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2024-12-18
- Latest
- 2026-01-08
- Applications
- 1